MedTrace Logo

COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens

NCT04715607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27947

Last updated 2021-09-30

No results posted yet for this study

Summary

The aim of this study is to compare the SARS-CoV-2 detection rate using either a Saliva, oropharyngeal swabs or nasopharyngeal swab method for specimen collection.

Conditions

  • SARS-CoV Infection
  • Covid19
  • Coronavirus

Interventions

DIAGNOSTIC_TEST

Sequence of testing.

The participants will be tested in the following sequences of sampling technique: (1) nasopharyngeal swab, oropharyngeal swab, and salvia collection OR (2) oropharyngeal swab, salvia collection, and nasopharyngeal swab OR (3) salvia collection, nasopharyngeal swab, and oropharyngeal swab. Only the sequence is different in the different arm, while the sampling technique for each method is the same in all arms.

Sponsors & Collaborators

  • Hvidovre University Hospital

    collaborator OTHER

  • Region Hovedstadens Apotek

    collaborator OTHER_GOV

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Tobias Todsen, MD, PhD · Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet

  • Nikolai Kirkby, MD, PhD · Department of Clinical Microbiology, Rigshospitalet

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-22
Primary Completion
2021-05-30
Completion
2021-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04715607 on ClinicalTrials.gov